OHSU @OHSUNews · 28 Aug 2026
Three years ago, Sarah Efron became the first patient in the world to be screened and enrolled in a new clinical trial to test aficamten against her nonobstructive form of hypertrophic cardiomyopathy. She says it has dramatically improved her condition. https://t.co/9tSXHZ3L4U
374Views
1Likes
0Reposts
0Replies
0Quotes
0Bookmarks
Is that a lot?
0.95×vs this author's median396 views is typical
38Percentile for this authorof 8 recent posts
0.21×vs 10K–100K median1 756 views is typical
2.05%Reachviews ÷ followers
0.27%Engagement rateof viewers reacted